Biotech Versus the Superbugs: Interviewing Centauri Therapeutics CSO Helen Bright

Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.

We dive into the archive of 2021 for insight and inspiration – this time with Peter Marks

We ask James Chambers from Tufts Medical Center about the challenges faced by biosimilars in the US.

Some scientists believe “dark” regions could be the key to understanding the relationship between our genetic makeup and diseases.

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally.

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems; we ask experts about the future of advanced medicine.

How fluid flow through the body can affect the ways in which antibiotics work.

Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr.